Trials advance and de-risk the Siviour Project: Renascor Resources

Junior explorer Renascor Resources (ASX: RNU) was up around 11% at lunch time today following today’s announced completion of the commercial-scale milling equipment trials for its planned graphite mine and battery anode manufacturing operation in South Australia.

Capturing the market’s attention were revelations that trials have achieved spherical graphite yields from the Siviour Graphite Deposit in excess of 65%.

These results compare favourably to a 50% yield adopted in the battery anode material study.

The spherical graphite produced from the trials met or exceeded physical customer specifications.

The trials

Data from the equipment trials will be used for engineering design works and final equipment selection for the company’s planned PSG facility.

The trials tested multiple milling and spheronisation technologies, with trials undertaken in Asia, the US and Europe at both equipment manufacturers and laboratories with milling test facilities.

A key objective of these mill trials was to maximise the amount of graphite that can be processed from Siviour Graphite Concentrates into a spherical form (Spherical Graphite) that meets the physical product specifications of Renascor’s existing and potential additional offtake partners.

Improved profit margins

As a result of this increased proportion of PSG material being produced per unit of graphite concentrate feed, Renascor noted the potential to produce more purified spherical graphite (PSG) and improve profit margins.

Renascor Managing Director David Christensen believes the completion of the downstream equipment trials is another important step in advancing and de-risking the Siviour Project.

Christensen also noted potential for improved yields offering further upside in the company’s plans to become a global leader in the production of high-quality, sustainable Purified Spherical Graphite products for lithium-ion battery anode makers worldwide.

“We look forward to using data generated from these trials to complete engineering design works and for final equipment selection for our manufacturing facility in South Australia.”

There is no consensus coverage on this stock.